Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men

Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men

Background. Advancing age, chronic inflammation, oxidative damage, and disorders of lipid metabolism are positively linked to the late-life cognitive impairment. Serum biomarkers may be associated with the cognitive status in older men. Methods. 440 old male subjects with different cognitive functio...

Full description

Bibliographic Details
Main Authors:	Cheng Ma, Jin Li, Zhijun Bao, Qingwei Ruan, Zhuowei Yu
Format:	Article
Language:	English
Published:	Hindawi Limited 2015-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2015/481621

Similar Items

HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
by: Kuang-Yuh eChyu, et al.
Published: (2015-09-01)

Polarized secretion of apoA-I and apoA-II by transfected MDCK cells.
by: A T Remaley, et al.
Published: (1995-03-01)

Differential tissue-specific expression of human apoA-I and apoA-II
by: TL Eggerman, et al.
Published: (1991-05-01)

ApoA-I and Cancer
by: Maryam eZamanian-Daryoush, et al.
Published: (2015-11-01)

GPI-specific phospholipase D associates with an apoA-I- and apoA-IV-containing complex
by: Mark A. Deeg, et al.
Published: (2001-03-01)

ApoA-I deficiency in mice is associated with redistribution of apoA-II and aggravated AApoAII amyloidosis[S]
by: Yaoyong Wang (王耀勇), et al.
Published: (2011-08-01)

SR-BI-mediated selective lipid uptake segregates apoA-I and apoA-II catabolism
by: Maria C. de Beer, et al.
Published: (2005-10-01)

SAA-only HDL formed during the acute phase response in apoA-I+/+ and apoA-I–/– mice
by: Veneracion G. Cabana, et al.
Published: (1999-06-01)

In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions
by: Catherine C. Hedrick, et al.
Published: (2001-04-01)

ApoA-IV promotes the biogenesis of apoA-IV-containing HDL particles with the participation of ABCA1 and LCAT[S]
by: Adelina Duka, et al.
Published: (2013-01-01)

ApoA-II maintains HDL levels in part by inhibition of hepatic lipase: studies in apoA-II and hepatic lipase double knockout mice
by: Wei Weng, et al.
Published: (1999-06-01)

Regulation of apoA-I gene expression
by: Stefania Lamon-Fava, et al.
Published: (2004-01-01)

Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent
by: Wilson James M, et al.
Published: (2007-05-01)

Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I
by: Marie-Claude Blatter Garin, et al.
Published: (2006-03-01)

Increased serum apoA-IV concentrations in experimental uremic rats.
by: M Seishima, et al.
Published: (1992-10-01)

Therapies to Increase ApoA-I and HDL-Cholesterol Levels
by: William M. Brown, et al.
Published: (2008-01-01)

Therapies to Increase ApoA-I and HDL-Cholesterol Levels
by: William M. Brown J.D., Ph.D., et al.
Published: (2008-01-01)

Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice
by: Hiroshi Hosoai, et al.
Published: (1999-04-01)

ApoA-II/apoA-I molar ratio in the HDL particle influences phospholipid transfer protein-mediated HDL interconversion.
by: P J Pussinen, et al.
Published: (1997-01-01)

Quality control in the apoA-I secretory pathway
by: Shaila Bhat, et al.
Published: (2004-07-01)

ApoA-I mimetics: tomatoes to the rescue1
by: Godfrey S. Getz, et al.
Published: (2013-04-01)

Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I*
by: Brian J. Van Lenten, et al.
Published: (2008-11-01)

Secretion of apoB- and apoA-I-containing lipoproteins by chick kidney
by: Patrizia Tarugi, et al.
Published: (1998-04-01)

Ratio determination of plasma wild-type and L159R apoA-I using mass spectrometry: tools for studying apoA-IFin
by: John S. Owen, et al.
Published: (2007-01-01)

ApoA-II kinetics in humans using endogenous labeling with stable isotopes: slower turnover of apoA-II compared with the exogenous radiotracer method
by: K Ikewaki, et al.
Published: (1996-02-01)

Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy
by: Jessica Camacho, et al.
Published: (2019-03-01)

Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro
by: Veneracion G. Cabana, et al.
Published: (2004-02-01)

Circulating HDL levels control hypothalamic astrogliosis via apoA-I
by: Anna Götz, et al.
Published: (2018-09-01)

ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes
by: A S Plump, et al.
Published: (1997-05-01)

Characterization of apoA- and apoB-containing lipoprotein particles in a variant of familial apoA-I deficiency with planar xanthoma: the metabolic significance of LP-A-II particles.
by: ED Bekaert, et al.
Published: (1991-10-01)

APOA1-75 G to A Substitution Associated with Severe Forms of CAD, Lower Levels of HDL and apoA-I among Northern Indians
by: S. Chhabra, et al.
Published: (2005-01-01)

ApoA-I secretion from HepG2 cells: evidence for the secretion of both lipid-poor apoA-I and intracellularly assembled nascent HDL
by: Jeffrey W. Chisholm, et al.
Published: (2002-01-01)

Adenoviral vector-mediated overexpression of serum amyloid A in apoA-I-deficient mice
by: N R Webb, et al.
Published: (1997-08-01)

ApoE2-associated hypertriglyceridemia is ameliorated by increased levels of apoA-V but unaffected by apoC-III deficiency*
by: Gery Gerritsen, et al.
Published: (2008-05-01)

HDL-apoA-I exchange: rapid detection and association with atherosclerosis.
by: Mark S Borja, et al.
Published: (2013-01-01)

Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer
by: Konstantina Georgila, et al.
Published: (2019-08-01)

A novel approach to oral apoA-I mimetic therapy[S]
by: Arnab Chattopadhyay, et al.
Published: (2013-04-01)

Mechanisms of HDL deficiency in mice overexpressing human apoA-II
by: Josep Julve, et al.
Published: (2002-10-01)

Effect of apoA-I on cholesterol release and apoE secretion in human mature adipocytes
by: Roche Régis, et al.
Published: (2010-07-01)

ApoA-IV modulates the secretory trafficking of apoB and the size of triglyceride-rich lipoproteins
by: Richard B. Weinberg, et al.
Published: (2012-04-01)